10+: Proven to help reduce Healthcare-associated Infections in 10 peer-reviewed, published studies over.
>5-log reduction of high-prevalence MDROs.
Dr. Margakis | Johns Hopkins Health System
25% Decrease in C. difficile Infections
Dr. Pegues | University of Pennsylvania
76% C. difficile + MRSA Reductions
Dr. Donskey | Cleveland Clinic
Direct and Indirect Inactivation of C. difficile and MRSA
Dr. Rutala | UNC Healthcare
Request a product demo, information or ask questions